Abstract

Diseases of the urinary tract and kidneys occupy a leading place in the structure of diseases all over the world. Arctostaphylos uva-ursi leaves are one of the most widely used types of medicinal plant materials (MPM) with diuretic and uroantiseptic action. However, a decoction from the leaves of Arctostaphylos uva-ursi has certain disadvantages: the duration of the manufacturing process of the dosage form, the lack of standardization before use, the inaccuracy of dosage and the short storage time of the dosage form, which leads to a low complementarity of this remedy, therefore, the development of standardized extracts from this raw material is relevant. The aim. The aim of the research was a phytochemical study of a phenylalanine-modified dry extract from the leaves of Arctostaphylos uva-ursi to establish the possibility of creating a new diuretic drug. Materials and methods. The object of the study was dry extract from the leaves of Arctostaphylos uva-ursi, modified with phenylalanine. Phytochemical studies of phenolic compounds and saponins were carried out by HPLC and spectrophotometry. Determination of diuretic activity was carried out according to the method of E.B. Berkhina on outbred rats. Determination of the anti-inflammatory activity of the obtained extracts was carried out by the method of carrageenan edema in white rats. The study of the antibacterial activity of the extracts was carried out by the method of diffusion into agar. Results. In the extracts obtained by HPLC, phenol glycoside (arbutin), 2 phenol carboxylic acids (gallic and ellagic), 6 flavonoids, 8 saponins were identified and their quantitative content was determined. Among flavonoids, hyperoside and catechin were dominant; among saponins, ursolic acid, uvaol, and lupeol were dominant. In the obtained extracts, the content of the main groups of phenolic compounds was determined by spectrophotometry. Dry extract of Arctostaphylos uva-ursi, modified with phenylalanine, showed pronounced diuretic, anti-inflammatory and antimicrobial (in relation to St. aureus, E. coli, P. vulgaris, P. aeruginosa, B. subtilis and C. albicans) activity. Conclusions. The chemical composition, diuretic, antimicrobial and anti-inflammatory activity of dry extract from Arctostaphylos uva-ursi leaves modified with phenylalanine were determined. The obtained dry extract is noted for better solubility, bioavailability and pharmacodynamics, therefore it is a promising substance for creating new drugs in various dosage forms

Highlights

  • Diseases of the urinary tract and kidneys occupy a leading place in the structure of diseases worldwide

  • The object of the study was a dry extract of Arcto-Studies of phenolic compounds of Arctostaphylos staphylos uva-ursi leaves, modified with phenylalanine. uvaursi extracts were performed by highperformance liquid chromatography (HPLC) on a liquid

  • Phenologlycoside, 2 phenolic acids, 6 flavonoids and 8 saponins were identified in the obtained extracts by HPLC and their quantitative content was determined

Read more

Summary

Introduction

Diseases of the urinary tract and kidneys occupy a leading place in the structure of diseases worldwide. In Ukraine, every fourth person is prone to diseases of the urinary system. It should be noted that the decoction of the leaves of Arctostaphylos uva-ursi has certain disadvantages: the duration of the manufacturing process of the dosage form, the lack of standardization before use, inaccurate dosing and short shelf life of the dosage form. All this leads to low complementarity of this medicine and as a consequence of the refusal of most patients to use such drugs [7, 8]

Objectives
Methods
Findings
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call